MedTrace Logo

Chemoradiotherapy Followed by Surgery for Advanced Paranasal Sinus Cancer

NCT00347256 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2008-12-10

No results posted yet for this study

Summary

The purpose of this study is to determine the efficacy of concurrent chemotherapy and radiotherapy pre-operatively in patients with advanced paranasal sinus cancer. The main objectives of this study are: 1) to measure the rate of complete response to preoperative chemoradiation and 2) to study the efficacy of combining preoperative chemoradiation and surgery in terms of local control of the cancer two years post treatment.

Conditions

  • Paranasal Sinus Neoplasms

Interventions

DRUG

cisplatin

PROCEDURE

targeted radiation therapy

PROCEDURE

tumor resection

Sponsors & Collaborators

  • North American Skull Base Society

    collaborator OTHER

  • University of Tennessee

    lead OTHER

Principal Investigators

  • Sandeep Samant, MS, FRCS · University of Tennessee

  • Sandeep Samant, MS, FRCS · University of Tennessee

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00347256 on ClinicalTrials.gov